nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Phlebitis—Carboplatin—esophageal cancer	0.0445	0.0445	CcSEcCtD
Aztreonam—Serum creatinine increased—Cisplatin—esophageal cancer	0.0252	0.0252	CcSEcCtD
Aztreonam—Joint swelling—Capecitabine—esophageal cancer	0.0233	0.0233	CcSEcCtD
Aztreonam—Sneezing—Capecitabine—esophageal cancer	0.0206	0.0206	CcSEcCtD
Aztreonam—Serum creatinine increased—Capecitabine—esophageal cancer	0.0186	0.0186	CcSEcCtD
Aztreonam—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.0169	0.0169	CcSEcCtD
Aztreonam—Laryngeal pain—Capecitabine—esophageal cancer	0.0167	0.0167	CcSEcCtD
Aztreonam—Pain—Carboplatin—esophageal cancer	0.0161	0.0161	CcSEcCtD
Aztreonam—Wheezing—Cisplatin—esophageal cancer	0.015	0.015	CcSEcCtD
Aztreonam—Body temperature increased—Carboplatin—esophageal cancer	0.0149	0.0149	CcSEcCtD
Aztreonam—Petechiae—Capecitabine—esophageal cancer	0.0139	0.0139	CcSEcCtD
Aztreonam—Extrasystoles—Capecitabine—esophageal cancer	0.0136	0.0136	CcSEcCtD
Aztreonam—Phlebitis—Cisplatin—esophageal cancer	0.013	0.013	CcSEcCtD
Aztreonam—Chest discomfort—Capecitabine—esophageal cancer	0.0129	0.0129	CcSEcCtD
Aztreonam—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.0126	0.0126	CcSEcCtD
Aztreonam—Nasal congestion—Cisplatin—esophageal cancer	0.0123	0.0123	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.0112	0.0112	CcSEcCtD
Aztreonam—Candida infection—Capecitabine—esophageal cancer	0.0109	0.0109	CcSEcCtD
Aztreonam—Blood creatinine increased—Cisplatin—esophageal cancer	0.0105	0.0105	CcSEcCtD
Aztreonam—Petechiae—Methotrexate—esophageal cancer	0.0103	0.0103	CcSEcCtD
Aztreonam—Mouth ulceration—Capecitabine—esophageal cancer	0.0103	0.0103	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0101	0.0101	CcSEcCtD
Aztreonam—Phlebitis—Capecitabine—esophageal cancer	0.00962	0.00962	CcSEcCtD
Aztreonam—Thrombophlebitis—Capecitabine—esophageal cancer	0.00957	0.00957	CcSEcCtD
Aztreonam—Sweating increased—Cisplatin—esophageal cancer	0.00946	0.00946	CcSEcCtD
Aztreonam—Swelling—Capecitabine—esophageal cancer	0.00939	0.00939	CcSEcCtD
Aztreonam—Vascular purpura—Capecitabine—esophageal cancer	0.00926	0.00926	CcSEcCtD
Aztreonam—Pancytopenia—Cisplatin—esophageal cancer	0.00923	0.00923	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00878	0.00878	CcSEcCtD
Aztreonam—Purpura—Capecitabine—esophageal cancer	0.0086	0.0086	CcSEcCtD
Aztreonam—Vaginal inflammation—Methotrexate—esophageal cancer	0.0085	0.0085	CcSEcCtD
Aztreonam—Stomatitis—Cisplatin—esophageal cancer	0.00844	0.00844	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00829	0.00829	CcSEcCtD
Aztreonam—Diplopia—Capecitabine—esophageal cancer	0.00829	0.00829	CcSEcCtD
Aztreonam—Vaginal infection—Methotrexate—esophageal cancer	0.00802	0.00802	CcSEcCtD
Aztreonam—Blood creatinine increased—Capecitabine—esophageal cancer	0.00776	0.00776	CcSEcCtD
Aztreonam—Mouth ulceration—Methotrexate—esophageal cancer	0.00768	0.00768	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00746	0.00746	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00746	0.00746	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00731	0.00731	CcSEcCtD
Aztreonam—Tinnitus—Cisplatin—esophageal cancer	0.00725	0.00725	CcSEcCtD
Aztreonam—Flushing—Cisplatin—esophageal cancer	0.00722	0.00722	CcSEcCtD
Aztreonam—Abdominal distension—Capecitabine—esophageal cancer	0.00721	0.00721	CcSEcCtD
Aztreonam—Thrombophlebitis—Methotrexate—esophageal cancer	0.00713	0.00713	CcSEcCtD
Aztreonam—Bronchospasm—Capecitabine—esophageal cancer	0.00704	0.00704	CcSEcCtD
Aztreonam—Sweating increased—Capecitabine—esophageal cancer	0.00698	0.00698	CcSEcCtD
Aztreonam—Pancytopenia—Capecitabine—esophageal cancer	0.0068	0.0068	CcSEcCtD
Aztreonam—Erythema—Cisplatin—esophageal cancer	0.00677	0.00677	CcSEcCtD
Aztreonam—Neutropenia—Capecitabine—esophageal cancer	0.0067	0.0067	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00654	0.00654	CcSEcCtD
Aztreonam—Ill-defined disorder—Cisplatin—esophageal cancer	0.00628	0.00628	CcSEcCtD
Aztreonam—Anaemia—Cisplatin—esophageal cancer	0.00626	0.00626	CcSEcCtD
Aztreonam—Stomatitis—Capecitabine—esophageal cancer	0.00622	0.00622	CcSEcCtD
Aztreonam—Jaundice—Capecitabine—esophageal cancer	0.00622	0.00622	CcSEcCtD
Aztreonam—Malaise—Cisplatin—esophageal cancer	0.00611	0.00611	CcSEcCtD
Aztreonam—Convulsion—Cisplatin—esophageal cancer	0.00587	0.00587	CcSEcCtD
Aztreonam—Myalgia—Cisplatin—esophageal cancer	0.00576	0.00576	CcSEcCtD
Aztreonam—Haemoglobin—Capecitabine—esophageal cancer	0.00576	0.00576	CcSEcCtD
Aztreonam—Hepatitis—Capecitabine—esophageal cancer	0.00573	0.00573	CcSEcCtD
Aztreonam—Haemorrhage—Capecitabine—esophageal cancer	0.00573	0.00573	CcSEcCtD
Aztreonam—Discomfort—Cisplatin—esophageal cancer	0.00569	0.00569	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00555	0.00555	CcSEcCtD
Aztreonam—Anaphylactic shock—Cisplatin—esophageal cancer	0.00553	0.00553	CcSEcCtD
Aztreonam—Erythema multiforme—Capecitabine—esophageal cancer	0.00542	0.00542	CcSEcCtD
Aztreonam—Thrombocytopenia—Cisplatin—esophageal cancer	0.00541	0.00541	CcSEcCtD
Aztreonam—Tinnitus—Capecitabine—esophageal cancer	0.00534	0.00534	CcSEcCtD
Aztreonam—Hyperhidrosis—Cisplatin—esophageal cancer	0.00534	0.00534	CcSEcCtD
Aztreonam—Flushing—Capecitabine—esophageal cancer	0.00532	0.00532	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—esophageal cancer	0.00528	0.00528	CcSEcCtD
Aztreonam—Hypotension—Cisplatin—esophageal cancer	0.00516	0.00516	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—esophageal cancer	0.00506	0.00506	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00503	0.00503	CcSEcCtD
Aztreonam—Erythema—Capecitabine—esophageal cancer	0.00499	0.00499	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—esophageal cancer	0.00499	0.00499	CcSEcCtD
Aztreonam—Paraesthesia—Cisplatin—esophageal cancer	0.00496	0.00496	CcSEcCtD
Aztreonam—Dyspnoea—Cisplatin—esophageal cancer	0.00493	0.00493	CcSEcCtD
Aztreonam—Dysgeusia—Capecitabine—esophageal cancer	0.00489	0.00489	CcSEcCtD
Aztreonam—Pain—Cisplatin—esophageal cancer	0.00472	0.00472	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—esophageal cancer	0.00463	0.00463	CcSEcCtD
Aztreonam—Ill-defined disorder—Capecitabine—esophageal cancer	0.00463	0.00463	CcSEcCtD
Aztreonam—Anaemia—Capecitabine—esophageal cancer	0.00461	0.00461	CcSEcCtD
Aztreonam—Feeling abnormal—Cisplatin—esophageal cancer	0.00455	0.00455	CcSEcCtD
Aztreonam—Malaise—Capecitabine—esophageal cancer	0.0045	0.0045	CcSEcCtD
Aztreonam—Vertigo—Capecitabine—esophageal cancer	0.00448	0.00448	CcSEcCtD
Aztreonam—Body temperature increased—Cisplatin—esophageal cancer	0.00437	0.00437	CcSEcCtD
Aztreonam—Cough—Capecitabine—esophageal cancer	0.00435	0.00435	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—esophageal cancer	0.00429	0.00429	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—esophageal cancer	0.00427	0.00427	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—esophageal cancer	0.00427	0.00427	CcSEcCtD
Aztreonam—Myalgia—Capecitabine—esophageal cancer	0.00425	0.00425	CcSEcCtD
Aztreonam—Chest pain—Capecitabine—esophageal cancer	0.00425	0.00425	CcSEcCtD
Aztreonam—Discomfort—Capecitabine—esophageal cancer	0.0042	0.0042	CcSEcCtD
Aztreonam—Confusional state—Capecitabine—esophageal cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Hypersensitivity—Cisplatin—esophageal cancer	0.00407	0.00407	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—esophageal cancer	0.00404	0.00404	CcSEcCtD
Aztreonam—Thrombocytopenia—Capecitabine—esophageal cancer	0.00399	0.00399	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—esophageal cancer	0.00398	0.00398	CcSEcCtD
Aztreonam—Asthenia—Cisplatin—esophageal cancer	0.00396	0.00396	CcSEcCtD
Aztreonam—Hyperhidrosis—Capecitabine—esophageal cancer	0.00394	0.00394	CcSEcCtD
Aztreonam—Hypotension—Capecitabine—esophageal cancer	0.00381	0.00381	CcSEcCtD
Aztreonam—Diarrhoea—Cisplatin—esophageal cancer	0.00378	0.00378	CcSEcCtD
Aztreonam—Erythema—Methotrexate—esophageal cancer	0.00371	0.00371	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00371	0.00371	CcSEcCtD
Aztreonam—Insomnia—Capecitabine—esophageal cancer	0.00368	0.00368	CcSEcCtD
Aztreonam—Paraesthesia—Capecitabine—esophageal cancer	0.00366	0.00366	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—esophageal cancer	0.00364	0.00364	CcSEcCtD
Aztreonam—Dyspnoea—Capecitabine—esophageal cancer	0.00363	0.00363	CcSEcCtD
Aztreonam—Vomiting—Cisplatin—esophageal cancer	0.00351	0.00351	CcSEcCtD
Aztreonam—Rash—Cisplatin—esophageal cancer	0.00348	0.00348	CcSEcCtD
Aztreonam—Pain—Capecitabine—esophageal cancer	0.00348	0.00348	CcSEcCtD
Aztreonam—Dermatitis—Cisplatin—esophageal cancer	0.00348	0.00348	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—esophageal cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—esophageal cancer	0.00343	0.00343	CcSEcCtD
Aztreonam—Feeling abnormal—Capecitabine—esophageal cancer	0.00336	0.00336	CcSEcCtD
Aztreonam—Malaise—Methotrexate—esophageal cancer	0.00335	0.00335	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—esophageal cancer	0.00334	0.00334	CcSEcCtD
Aztreonam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00333	0.00333	CcSEcCtD
Aztreonam—Nausea—Cisplatin—esophageal cancer	0.00328	0.00328	CcSEcCtD
Aztreonam—Cough—Methotrexate—esophageal cancer	0.00324	0.00324	CcSEcCtD
Aztreonam—Urticaria—Capecitabine—esophageal cancer	0.00324	0.00324	CcSEcCtD
Aztreonam—Body temperature increased—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Abdominal pain—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—esophageal cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—esophageal cancer	0.00316	0.00316	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—esophageal cancer	0.00316	0.00316	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—esophageal cancer	0.00312	0.00312	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—esophageal cancer	0.00306	0.00306	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—esophageal cancer	0.00303	0.00303	CcSEcCtD
Aztreonam—Hypersensitivity—Capecitabine—esophageal cancer	0.003	0.003	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—esophageal cancer	0.00297	0.00297	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—esophageal cancer	0.00293	0.00293	CcSEcCtD
Aztreonam—Asthenia—Capecitabine—esophageal cancer	0.00292	0.00292	CcSEcCtD
Aztreonam—Pruritus—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—esophageal cancer	0.00283	0.00283	CcSEcCtD
Aztreonam—Diarrhoea—Capecitabine—esophageal cancer	0.00279	0.00279	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00276	0.00276	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—esophageal cancer	0.00274	0.00274	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—esophageal cancer	0.00272	0.00272	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—esophageal cancer	0.0027	0.0027	CcSEcCtD
Aztreonam—Dizziness—Capecitabine—esophageal cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Pain—Methotrexate—esophageal cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Vomiting—Capecitabine—esophageal cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Rash—Capecitabine—esophageal cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Dermatitis—Capecitabine—esophageal cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Headache—Capecitabine—esophageal cancer	0.00255	0.00255	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—esophageal cancer	0.0025	0.0025	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00248	0.00248	CcSEcCtD
Aztreonam—Nausea—Capecitabine—esophageal cancer	0.00242	0.00242	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—esophageal cancer	0.00241	0.00241	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—esophageal cancer	0.0024	0.0024	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—esophageal cancer	0.0024	0.0024	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—esophageal cancer	0.00223	0.00223	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—esophageal cancer	0.00218	0.00218	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—esophageal cancer	0.00215	0.00215	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—esophageal cancer	0.00207	0.00207	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—esophageal cancer	0.002	0.002	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—esophageal cancer	0.00193	0.00193	CcSEcCtD
Aztreonam—Rash—Methotrexate—esophageal cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—esophageal cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Headache—Methotrexate—esophageal cancer	0.0019	0.0019	CcSEcCtD
Aztreonam—Nausea—Methotrexate—esophageal cancer	0.0018	0.0018	CcSEcCtD
